Halifax – Rns news

Source: Sharecast

RNS Number : 7650L

Barclays PLC

09 July 2026

FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
Rule 8.3 of the Takeover Code (the "Code")
1.				KEY INFORMATION
(a)	Full name of discloser:				Barclays PLC.
(b)	Owner or controller of interest and short
	positions disclosed, if different from 1(a):
(c)	Name of offeror/offeree in relation to whose				ADVANCED MEDICAL SOLUTIONS GROUP PLC
	relevant securities this form relates:
(d)	If an exempt fund manager connected with an
	offeror/offeree, state this and specify identity of
	offeror/offeree:
(e)	Date position held/dealing undertaken:				08 Jul 2026
(f)	In addition to the company in 1(c) above, is the discloser making				NO
	disclosures in respect of any other party to the offer?
2.				POSITIONS OF THE PERSON MAKING THE DISCLOSURE
(a)	Interests and short positions in the relevant securities of the offeror or offeree
	to which the disclosure relates following the dealing(if any)
Class of relevant security:				5p ordinary
				Interests		Short Positions
				Number	(%)	Number	(%)
(1)	Relevant securities owned
	and/or controlled:			3,434,234	1.56%	2,144,446	0.97%
(2)	Cash-settled derivatives:
				2,077,527	0.94%	3,429,464	1.55%
(3)	Stock-settled derivatives (including options)
	and agreements to purchase/sell:			0	0.00%	0	0.00%

	TOTAL:			5,511,761	2.50%	5,573,910	2.52%
(b)	Rights to subscribe for new securities (including directors and other executive
	options)
Class of relevant security in relation to
which subscription right exists
Details, including nature of the rights
concerned and relevant percentages:
3.				DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
(a)	Purchases and sales
Class of relevant		Purchase/sale		Number of		Price per unit
security				securities
5p ordinary		Purchase		658,208		2.8000 GBP
5p ordinary		Purchase		69,830		2.7850 GBP
5p ordinary		Purchase		57,894		2.7884 GBP
5p ordinary		Purchase		44,924		2.7870 GBP
5p ordinary		Purchase		42,774		2.7910 GBP
5p ordinary		Purchase		34,893		2.7853 GBP
5p ordinary		Purchase		24,906		2.7858 GBP
5p ordinary		Purchase		19,925		2.7882 GBP
5p ordinary		Purchase		13,225		2.7923 GBP
5p ordinary		Purchase		8,948		2.7859 GBP
5p ordinary		Purchase		7,377		2.7875 GBP
5p ordinary		Purchase		4,527		2.7894 GBP
5p ordinary		Purchase		3,468		2.7944 GBP
5p ordinary		Purchase		1,571		2.7865 GBP
5p ordinary		Purchase		376		2.7821 GBP
5p ordinary		Purchase		26		2.7873 GBP
5p ordinary		Purchase		21		2.7950 GBP
5p ordinary		Sale		70,382		2.7950 GBP
5p ordinary		Sale		39,525		2.7880 GBP
5p ordinary		Sale		38,698		2.7850 GBP
5p ordinary		Sale		16,521		2.7892 GBP
5p ordinary		Sale		14,244		2.7887 GBP
5p ordinary		Sale		5,312		2.7900 GBP
5p ordinary		Sale		4,527		2.7895 GBP
5p ordinary		Sale		3,200		2.7951 GBP
5p ordinary		Sale		1,100		2.7868 GBP
5p ordinary		Sale		148		2.7905 GBP

(b)	Cash-settled derivative transactions
Class of		Product		Nature of dealing		Number of	Price per
relevant		description				reference	unit
security						securities
5p ordinary		SWAP		Decreasing Long		645	2.7895 GBP
5p ordinary		SWAP		Decreasing Long		608	2.7890 GBP
5p ordinary		SWAP		Decreasing Long		500	2.7950 GBP
5p ordinary		SWAP		Increasing Short		24,906	2.7858 GBP
5p ordinary		SWAP		Decreasing Long		658,028	2.8000 GBP
5p ordinary		SWAP		Increasing Long		2,100	2.7848 GBP
5p ordinary		SWAP		Increasing Short		441,026	2.8000 GBP
5p ordinary		CFD		Increasing Short		79,283	2.7853 GBP
5p ordinary		CFD		Decreasing Long		27,143	2.7944 GBP
5p ordinary		SWAP		Decreasing Long		32	2.7887 GBP
5p ordinary		SWAP		Increasing Short		75,532	2.7879 GBP
5p ordinary		CFD		Increasing Short		4,022	2.7851 GBP
5p ordinary		CFD		Increasing Long		4,984	2.7848 GBP
5p ordinary		SWAP		Decreasing Long		237	2.7900 GBP
5p ordinary		SWAP		Increasing Short		246	2.7900 GBP
5p ordinary		SWAP		Increasing Long		195	2.7850 GBP
5p ordinary		SWAP		Decreasing Short		2,960	2.7850 GBP
5p ordinary		SWAP		Decreasing Short		70,382	2.7950 GBP

(c)	Stock-settled derivative transactions (including options)
(i)	Writing, selling, purchasing or varying
Class	Product	Writing,	Number	Exercise	Type	Expiry	Option
of	description	purchasing,	of	price		date	money
relevant		selling,	securities	per unit			paid/
security		varying etc	to which				received
			option				per unit
			relates


(ii)	Exercise
Class of relevant		Product description		Exercising/ exercised against		Number of	Exercise price per
security						securities	unit


(d)	Other dealings (including subscribing for new securities)
Class of relevant		Nature of Dealings		Details		Price per unit (if
security						applicable)

4.				OTHER INFORMATION
(a)	Indemnity and other dealings arrangements
Details of any indemnity or option arrangement, or any agreement or understanding,
formal or informal, relating to relevant securities which may be an inducement to deal
or refrain from dealing entered into by the exempt principal trader making the disclosure and any party
to the offer or any person acting in concert with a party to the offer:
NONE
(b)	Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal, between
the person making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights of future acquisition or disposal of any relevant securities to which
any derivative is referenced:
NONE
(c)	Attachments
Is a Supplemental Form 8 (Open Positions) attached?				NO
Date of disclosure:				09 Jul 2026
Contact name:				Large Holdings Regulatory Operations
Telephone number:				020 3134 7213

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RETMZGGNFLNGVZM

Form 8.3 ADVANCED MEDICAL SOLUTIONS GROUP PLC.

Compare our accounts